Detailed answers about ADEXA LABZ & DIAGNOSTICS LTD, including incorporation, status, business activity, and accounts information.
When was ADEXA LABZ & DIAGNOSTICS LTD founded?
ADEXA LABZ & DIAGNOSTICS LTD was officially incorporated on 3 July 2026 and is registered under company number 17316999. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ADEXA LABZ & DIAGNOSTICS LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of ADEXA LABZ & DIAGNOSTICS LTD?
ADEXA LABZ & DIAGNOSTICS LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does ADEXA LABZ & DIAGNOSTICS LTD do?
ADEXA LABZ & DIAGNOSTICS LTD operates in the following sectors: 47410 - Retail sale of computers, peripheral units and software in specialised stores, 47749 - Retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c., 62012 - Business and domestic software development, 86900 - Other human health activities. These SIC codes provide insight into the company's business activities and industry focus.
What is ADEXA LABZ & DIAGNOSTICS LTD's registered address?
The registered office address of ADEXA LABZ & DIAGNOSTICS LTD is 66 Paul Street, London, England, United Kingdom, EC2A 4NA. This is the official address filed with Companies House for legal and statutory correspondence.
Is ADEXA LABZ & DIAGNOSTICS LTD financially stable?
Financial accounts for ADEXA LABZ & DIAGNOSTICS LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.